Polymorphic Forms of a Gabaa Agonist
    5.
    发明申请
    Polymorphic Forms of a Gabaa Agonist 有权
    Gabaa激动剂的多形态

    公开(公告)号:US20080085913A1

    公开(公告)日:2008-04-10

    申请号:US11813796

    申请日:2006-01-26

    CPC分类号: C07D498/04

    摘要: The present invention is directed to novel polymorphic forms of the compound 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol hydrate (gaboxadol monohydrate). The invention is further concerned with pharmaceutical compositions containing the polymorphic forms as an active ingredient, methods for treatment of disorders susceptible to amelioration by GABAA receptor agonism with the polymorphic forms, and processes for the preparation of the polymorphic forms.

    摘要翻译: 本发明涉及化合物4,5,6,7-四氢异恶唑并[5,4-c]吡啶-3-醇水合物(加波沙朵一水合物)的新型多晶型物。 本发明进一步涉及含有多晶型物作为活性成分的药物组合物,用多巴胺形式治疗易受GABA A受体激动作用改善的病症的方法,以及多晶型物的制备方法。

    Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
    6.
    发明申请
    Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane 审中-公开
    合成(+)和( - ) - 1-(3,4-二氯苯基)-3-氮杂双环[3.1.0]己烷的方法

    公开(公告)号:US20080045725A1

    公开(公告)日:2008-02-21

    申请号:US11740667

    申请日:2007-04-26

    IPC分类号: C07D209/00

    摘要: The present invention is concerned with novel processes for the preparation of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or a pharmaceutically acceptable salt thereof, and (−)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or a pharmaceutically acceptable salt thereof. These compounds have pharmaceutical utility and are known to be useful for treating e.g., depression, anxiety disorders, eating disorders and urinary incontinence.

    摘要翻译: 本发明涉及制备(+) - 1-(3,4-二氯苯基)-3-氮杂双环[3.1.0]己烷或其药学上可接受的盐的新方法,和( - ) - 1- 3,4-二氯苯基)-3-氮杂双环[3.1.0]己烷或其药学上可接受的盐。 这些化合物具有药物效用并且已知可用于治疗例如抑郁症,焦虑障碍,进食障碍和尿失禁。